Group Justice? Legal Moves That Lump Pharma Cases Together Are Bad For Justice And Bad For The Industry
Abstract
This article critiques the judicial penchant for combining drug and device tort cases together for adjudication, and posits that the functional challenges encountered with such efficiencies compromise the essential truth-finding process of such litigation.
Suggested Citation
William M. Janssen. "Group Justice? Legal Moves That Lump Pharma Cases Together Are Bad For Justice And Bad For The Industry" PHARMACEUTICAL EXECUTIVE (2004).
The full text of this version of the article is not currently available here.
Find in your library
Bookmark
Bookmark